Also, it is plausible that the effect of severity of anaemia or RBCT may not have been detected due to wide variation in urine (I-FABP, L-FABP and TFF-3) and stool (Calprotectin) biomarker values documented in this study. The gene discussed is FABP1; the disease is anemia.